ArticleJournal of biomedical science2026
Smyca-FOXM1 ribonucleoprotein complex promotes homologous recombination and tumor immune evasion to define a therapeutic target of triple-negative breast cancer.
Han-Hsiun Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.